It has also been proposed that miR-92d-3p inhibits the progression of diabetic nephropathy (DN) by inhibiting the activation of C3/HMGB1/TGF-β1 pathway and EMT 43. The gene discussed is TGFB1; the disease is liver dysplastic nodule.